Brief: Lasa Supergenerics Gets FDA Nod For Progesterone
13/04/2020 10:37
April 13 (Reuters) - Lasa Supergenerics Ltd LASA.NS :
* GETS FDA NOD FOR PROGESTERONE
Source text for Eikon: ID:nBSE6wVPn3
Further company coverage: LASA.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Lasa Supergenerics
See all newsBrief: Lasa Supergenerics Provides Update On Fire Incident
Brief: Lasa Supergenerics Approves Rights Issue To Raise Up To 490 Mln Rupees
Brief: Lasa Supergenerics To Consider Issue Of Warrants Convertible Into Equity Shares
India's Lasa Supergenerics gains after settlement of dues
Brief: Lasa Supergenerics Says Dispute With Bank Of Baroda Settled